Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M108491200 on December 31, 2001

J. Biol. Chem., Vol. 277, Issue 10, 8702-8707, March 8, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8702    most recent
M108491200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, J. R.
Right arrow Articles by Nardulli, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J. R.
Right arrow Articles by Nardulli, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Modulation of DNA Conformation by Estrogen Receptors alpha  and beta *

Jennifer R. SchultzDagger §, Margaret A. LovenDagger , Vida M. Senkus Melvin, Dean P. Edwards||, and Ann M. NardulliDagger **

From the Dagger  Department of Molecular and Integrative Physiology, University of Illinois, Urbana, Illinois 61801, and the  Molecular Biology Program and the || Department of Pathology, University of Colorado, Denver, Colorado 80262

Received for publication, September 4, 2001, and in revised form, December 14, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The human estrogen receptor (ER) induces transcription of estrogen-responsive genes upon binding to estrogen and the estrogen response element (ERE). To determine whether receptor-induced changes in DNA structure are related to transactivation, we compared the abilities of ERalpha and ERbeta to activate transcription and induce distortion and bending in DNA. ERalpha induced higher levels of transcription than ERbeta in the presence of 17beta -estradiol. In circular permutation experiments ERalpha induced greater distortion in DNA fragments containing the consensus ERE sequence than ERbeta . Phasing analysis indicated that ERalpha induced a bend directed toward the major groove of the DNA helix but that ERbeta failed to induce a directed DNA bend. Likewise, the ERalpha DNA binding domain (DBD) and hinge region induced a bend directed toward the major groove of the DNA helix, but the ERbeta DBD and hinge region failed to bend ERE-containing DNA fragments. Using receptor chimeras we demonstrated that the ERalpha DBD C-terminal extension is required for directed DNA bending. Transient transfection assays revealed that appropriately oriented DNA bending enhances receptor-mediated transactivation. The different abilities of ERalpha and ERbeta to induce change in DNA structure could foster or inhibit the interaction of regulatory proteins with the receptor and other transcription factors and help to explain how estrogen-responsive genes are differentially regulated by these two receptors.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Estrogen is a hormone of critical importance in regulating the development, growth, and maintenance of reproductive tissues and also influences cardiovascular, neural, and skeletal cell function (1-6). The effects of estrogen are mediated through interaction of the estrogen receptor (ER)1 with estrogen response elements (EREs) residing in target genes. Because the ER-ERE interaction plays such a crucial role in gene expression, there has been and continues to be great interest in understanding how this interaction leads to changes in transcription.

With the recent revelation that two ER subtypes exist, the previously identified ERalpha (7-10) and the more recently cloned ERbeta (11-14), our vision of how estrogen brings about its effects in target cells must now be reevaluated and take into consideration the actions of both receptor subtypes. Although the amino acid sequence in the DNA and hormone binding domains of ERalpha and ERbeta is highly conserved, other regions of the two receptors are more varied (15). These differences in amino acid sequence affect the affinities of ERalpha and ERbeta for various ligands and ERE sequences, influence the association of the receptors with coactivator proteins, and thereby alter the abilities of these two receptors to modulate gene expression (13, 14, 16-25).

A number of thermodynamic and structural studies have demonstrated that specific contacts between protein and DNA are often accompanied by conformational changes in protein, DNA, or both (26-31). We and others have demonstrated that binding of ERalpha to ERE-containing DNA fragments induces conformational changes in DNA structure suggesting that the ability of ERalpha to induce changes in DNA structure may be related to its ability to activate transcription (32-40). To determine whether ERbeta was capable of altering DNA conformation and whether ERalpha - and ERbeta -induced transcription activation might be related to the abilities of these two receptors to induce conformational changes in DNA structure, we have compared the abilities of ERalpha and ERbeta to activate transcription and induce flexibility and directed bending in ERE-containing DNA fragments and determined the effects of DNA bending on transcription activation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transient Transfections-- Transient cotransfections carried out with Chinese hamster ovary (CHO) cells utilized 3 µg of the CAT reporter plasmid, ERE TATA-CAT (41), which contains an ERE in the BglII site of ATC0, 200 ng of the beta -galactosidase expression vector pCH110 (Amersham Biosciences, Inc.), and 5 ng of the human ERalpha expression vector pCMV5 hER (42) or the human ERbeta expression vector pCMV5 hERbeta (43). Transient transfections carried out in U2 osteosarcoma (U2-OS) cells utilized 25 ng of ERalpha or ERbeta expression vector and 3 µg of a CAT reporter plasmid containing an ERE in the SalI site of ATC0 (ATC1, Ref. 44) alone or in combination with an intrinsically bent DNA sequence (ATC1-OP and ATC1-IP, previously described as 3A6/ERE3-CAT and 3A6/ERE3.4-CAT, Ref. 36). Cells were transfected with Lipofectin (Life Technologies, Inc.) as described (25). CAT activity was quantitated as described (24). beta -galactosidase activity was determined (45) and used to normalize for transfection efficiency.

Construction of ERbeta CD Expression Vector and Preparation of DNA Probes-- To construct the CDbeta expression vector, nucleotides encoding amino acids 134-260 of the ERbeta (DBD and hinge regions) were PCR amplified using the hERbeta expression vector pCMV5hERbeta and primers with 5'-NheI and 3'-HindIII compatible sites (forward primer: 5'-GCTATGGCTAGCCCTGTTACTGGTCCA-3' and reverse primer: 5'-GAGTCTAAGCTTTACTACAGCAGCAGCTCCCGCAC-3'). Oligonucleotides encoding the FLAG epitope (MDYKDDDK) with 5'-NdeI and 3'-NheI restriction enzyme sites (forward oligo: 5'-TATGGACTACAAGGACGACGATGACAAGG-3' and reverse oligo: 5'-CTAGCCTTGTCATCGTCGTCCTTGTAGTCCA-3') were annealed and ligated to NheI and HindIII-digested PCR product. The resulting fragment (flag:hERbeta DBD) was ligated to the NdeI/HindIII-cut pET-28a(+) and used to transform the DH5alpha strain of Escherichia coli. Plasmids were checked for insertion of the flag:hERbeta DBD fragment by digestion with RsaI, and the junctions of the pET-28a(+):flag:hERbeta DBD plasmid were verified by DNA sequencing.

Expression and Purification of Wild Type and Truncated ERalpha and ERbeta Proteins-- FLAG-tagged ERalpha and ERbeta were expressed and purified as previously described (23, 24). Protein purity was assayed by Coomassie blue-stained SDS-PAGE. ER concentration was determined using a hydroxyapatite binding assay (24).

CDalpha , which contained the DBD and hinge region of ERalpha , was expressed using the expression vector pET-21b(+):flag:hERalpha DBD (39) kindly provided by David J. Shapiro (University of Illinois, Urbana, IL). CDbeta was constructed as described above to encode the region of ERbeta (amino acids 134-260) corresponding to the region included in the ERalpha construct (amino acids 166-307). 500-ml cultures of transformed BL21DE3plysS cells were induced with 1 mM isopropyl-1-thio-beta -d-galactopyranosideisopropyl-1-thio-beta -D-galactopyranoside. 10 µM ZnCl2 was added to help stabilize the DBD zinc fingers. Induced cultures were incubated for 3 h with shaking at 37 °C and then chilled on ice for 5 min and pelleted at 4700 × g for 5 min at 4 °C. Cells were lysed with one freeze/thaw cycle. 5 ml of TEGDZ (50 mM Tris, pH 7.5, 1 mM EDTA, pH 8.0, 10% glycerol, 5 mM dithiothreitol, 50 µM ZnCl2, 25 µg/ml aprotinin, 5 µg/ml phenylmethylsulfonyl fluoride, 50 µg/ml leupeptin, 1 µg/ml pepstatin) with 0.5% Triton X-100 was added to the cell lysate and incubated with rotation for 30 min at 4 °C. The lysate was centrifuged at 142,000 × g for 30 min at 4 °C, and the pellet was discarded. Polyethyleneimine was added dropwise to the supernatant to 0.1%, incubated on ice for 10 min, and centrifuged at 142,000 × g for 30 min at 4 °C. The extract was diluted with 2 ml of TEGDZ and incubated with anti-FLAG M2 agarose (A1205, Sigma) with rotation for 4 h at 4 °C. The CD-antibody complexes were washed and eluted as described for the full-length receptors (23, 24), except that the wash and elution buffers for CDalpha contained 400 mM NaCl.

Plasmids encoding CDalpha /beta (amino acids 189-250 of ERalpha and 219-256 of ERbeta ) and CDbeta /alpha (amino acids 148-218 of ERbeta and 251-288 of ERalpha ) GST fusion proteins were cloned, expressed, and purified as described (46). The GST moiety was removed by overnight digestion with 0.02 units/µl thrombin.

Protein purity of CDalpha , CDbeta , CDalpha /beta , and CDbeta /alpha was assessed on Coomassie blue-stained SDS-PAGE. Protein concentrations were determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA) with bovine serum albumin as a standard.

Preparation of DNA Probes-- Circular permutation experiments were carried out with 427-bp DNA fragments isolated from the DNA bending vector B3ConsERE (41). B3ConsERE was digested with EcoRI, HindIII, EcoRV, NheI, or BamHI to produce DNA fragments containing a consensus ERE near the 3' end, at an intermediate 3' position, in the middle of the fragment, at an intermediate 5' position, or near the 5' end, respectively. All DNA fragments were composed of identical nucleotide sequence and differed only in the location of the ERE. The DNA fragments were isolated and 32P labeled as described (32).

Phasing analysis experiments were carried out with 280-290-bp DNA fragments containing an ERE 26, 28, 30, 32, 34, or 36-bp upstream of an intrinsic DNA bend. The DNA fragments were labeled as described (36). Vectors for DNA bending standards (47), were kindly provided by A. Landy (Brown University, Providence, RI). DNA bending standards were prepared as described (32, 33).

Gel Mobility Shift Assays-- For circular permutation analysis, gel mobility shift assays were performed with 50 fmol of purified baculovirus-expressed ERalpha or ERbeta and 5000 cpm of 32P-labeled ERE containing DNA fragments in binding buffer (10% glycerol, 2 µg of bovine serum albumin, 4 mM dithiothreitol, 15 mM Tris, pH 7.9, 0.2 mM EDTA, pH 8.0) with 20 mM KCl, 50 ng of polydeoxyinosine-polydeoxycytidine poly (dI/dC), and 50 nM E2.

For phasing analysis, gel mobility shift assays were performed with 10,000 cpm of 32P-labeled DNA fragments containing an ERE and an intrinsic DNA bend in binding buffer with 50 µM ZnCl2. Full-length receptor assays used 100 fmol of purified baculovirus-expressed ERalpha or ERbeta and included 50 ng of poly(dI/dC), 20 mM KCl, and 50 nM E2 in the binding reaction buffer. Assays with truncated DBD-hinge proteins used 350 or 600 fmol of purified, bacterially expressed CDalpha or CDbeta , respectively, and included 100 ng of poly(dI/dC) and 50 mM KCl (CDalpha ) or no additional KCl (CDbeta ) in the binding buffer. Assays with chimeric DBD-CTE proteins utilized 50 or 10 fmol of purified, bacterially expressed CDalpha /beta or CDbeta /alpha , respectively, and included 100 ng of poly (dI/dC) and 50 mM or 10 mM KCl in the binding buffer. Reactions were incubated for 10-15 min at room temperature prior to fractionation on low ionic strength polyacrylamide gels (48) at 4 °C with buffer recirculation. 2500 cpm each of NheI- or BamHI-digested bending standards were included on each gel.

The migration distances of the ER-DNA complexes, free probe, and DNA bending standards were determined using a Molecular Dynamics PhosphorImager and ImageQuant software (Molecular Dynamics, Sunnyvale, CA).

Calculation of DNA Distortion and Bending Angles-- The magnitude of each ER-induced distortion angle was determined from circular permutation experiments using two methods. The magnitude of the distortion angle was determined graphically by plotting the relative mobilities of the DNA bending standards (47) as a function of their known DNA bend angles. Polynomial regression analysis was used to determine the distortion angles induced by ERalpha and ERbeta . Distortion angles were also determined using the empirical equation µme = cos (kalpha /2), where µm is the relative mobility when the DNA bend is at the middle of the fragment and µe is the relative mobility when the bend is at the end of the fragment (47). A k value of 1.130 was determined by comparing the relative mobility of the DNA bending standards with the known bend angles as described (37). Calculations of DNA distortion angles are presented as the mean ± S.E. from four (ERalpha ) or six (ERbeta ) independent experiments.

The magnitude of the directed DNA bend was determined from phasing analysis experiments by comparing the relative mobility of each ER-DNA complex with the relative mobility of the DNA bending standards. The magnitude of the directed bend angle (alpha B) was determined using the equation tan (kalpha B/2) = (APH/2)/(tan(kalpha C/2)) where alpha C is the intrinsic bend (49). The k value of 1.154 was determined as described for circular permutation analysis. The relative mobility of each ER-DNA complex was calculated by dividing the mobility of the ER-DNA complex by the mobility of the corresponding uncomplexed DNA fragment. Interexperimental variation was eliminated by dividing the relative mobility of the ER-DNA complex by the average relative mobility to obtain the normalized relative mobility (µ). The amplitude of phasing, APH, was calculated by subtracting µmin from µmax. The fragment that migrated the farthest was determined using the greatest normalized relative mobility (µmax). Calculations for directed bend angles are presented as the mean ± S.E. from 4 (ERalpha ), 10 (ERbeta ), 11 (CDalpha ), 8 (CDbeta ), or 6 (CDalpha /beta and CDbeta /alpha ) independent experiments.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

ERalpha and ERbeta Activate Transcription to Different Extents-- Transient transfection assays were used to examine the ability of ERalpha and ERbeta to activate transcription of a CAT reporter vector containing a single consensus ERE. CHO cells were transiently transfected with an ERalpha or ERbeta expression vector, a CAT reporter plasmid containing a consensus ERE upstream of a TATA box, and a beta -galactosidase control vector. Both receptors significantly induced transcription in the presence of 10 nM E2 when compared with an ethanol vehicle (Fig. 1, p < 0.0001). ERalpha and ERbeta induced 19- and 11-fold increases in transcription, respectively. Similar results were obtained in U2-OS cells.2 Thus, ERalpha was a more potent activator of transcription than ERbeta .


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   ERalpha - and ERbeta -mediated transcription. CHO cells were transiently transfected with a human ERalpha or ERbeta expression vector, the ERE-containing reporter plasmid, ERE TATA-CAT, and a beta -galactosidase control vector using Lipofectin and treated with vehicle (open bars) or 10 nM E2 (closed bars). Data from three independent experiments were combined and are expressed as the mean ± S.E. Student's t tests were used to determine whether statistical differences between ethanol and E2-treated groups existed. Asterisks (*) indicate significant differences in CAT activity in the ethanol- and E2-treated cells (p < 0.0001).

ERalpha and ERbeta Induce Distortion in ERE-containing DNA Fragments-- Previous studies from our laboratory have demonstrated that binding of ERalpha to ERE-containing DNA fragments induces distortion and directed DNA bending (32-39). These studies and others suggest that the ability of a protein to induce conformational changes in DNA structure may be related to its ability to enhance transcription (50-52). To determine whether ERbeta induces distortion in ERE-containing DNA fragments and whether the magnitude of distortion might be related to the ability of ERalpha and ERbeta to activate transcription, circular permutation analysis was carried out with ERalpha and ERbeta . Circular permutation assays assess the migration of protein-DNA complexes through a native acrylamide gel to determine the magnitude of protein-induced DNA distortion. Because the geometry of a DNA fragment affects its migration through an acrylamide gel, a DNA fragment with a distortion near the end will migrate farther through the gel matrix than a DNA fragment with a distortion in the middle.

427-bp 32P-labeled DNA fragments containing a consensus ERE near the end, in the middle, or at an intermediate position in the DNA fragment were incubated with purified, baculovirus-expressed ERalpha or ERbeta and fractionated on a nondenaturing polyacrylamide gel. DNA bending standards, which contained 54, 72, or 90 ° intrinsic DNA bends (53, 54) were also included on all gels. As seen in Fig. 2A, distinct differences in the migration of the ER-bound DNA fragments were observed with both ERalpha and ERbeta . The migration of the receptor-DNA complexes was dependent on the location of the ERE in the DNA fragment. When the ERE was near the end of the DNA fragment (R, B), the ER-DNA complex migrated farther than when the ERE was present at an intermediate position in the DNA fragment (H, N). When the ERE was at the middle of the DNA fragment (V), the ER-DNA complex migrated even more slowly indicating that both ERalpha and ERbeta induced distortion in DNA structure. The magnitude of distortion was determined from four (ERalpha ) or six (ERbeta ) independent experiments using two methods. Graphical analysis, which compares the relative mobilities of the receptor-DNA complexes with the relative mobilities of the DNA bending standards (Fig. 2B), indicated that ERalpha and ERbeta induced distortion angles of 74.6 ± 4.1° and 63.9 ± 0.9°, respectively. Using the empirical equation µme = cos (kalpha /2) (47), similar distortion angles were obtained for ERalpha (76.0 ± 4.3°) and ERbeta (64.5 ± 1.0°). Thus, both ERalpha and ERbeta induce distortion in ERE-containing DNA fragments, but ERalpha induces a larger distortion angle than ERbeta (p < 0.05 comparing ERalpha to ERbeta by Student's t test).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   ERalpha - and ERbeta -induced DNA distortion. A, 32P-labeled DNA fragments containing a single consensus ERE at the 3' (R) or 5' (B) end, at an intermediate 3' (H) or 5' (N) position, or in the middle (V) were incubated with purified, baculovirus-expressed ERalpha or ERbeta and fractionated on a nondenaturing polyacrylamide gel. 32P-labeled DNA bending standards containing A6-tracts with 54, 72, or 90 ° bends in the middle (upper bands) or end (lower bands) of the DNA fragment were included on the same gel. B, a standard curve was developed by plotting the relative mobilities of the bending standards against their corresponding distortion angles. The distortion angles induced by ERalpha and ERbeta were determined by plotting the relative mobilities of the ERalpha - or ERbeta -DNA complexes on the standard curve.

ERalpha , but Not ERbeta , Induces a DNA Bend toward the Major Groove of the DNA Helix-- Circular permutation analysis can be used to determine the degree of distortion or flexibility induced by protein binding, but it does not provide information about the orientation of a DNA bend. To determine the magnitude and direction of receptor-induced DNA bending, phasing analysis was carried out. This assay utilizes DNA fragments with an ERE 26, 28, 30, 32, 34, or 36 bp upstream of an intrinsic DNA bend so that the orientation of the ER-induced and the intrinsic DNA bends are incrementally varied over one turn of the DNA helix. At some point the ER-induced and intrinsic DNA bends will be in phase, a larger DNA bend will be produced, and the migration of the ER-DNA complex through the gel matrix will be inhibited. Likewise, at some point the ER-induced and intrinsic DNA bends will be out of phase, the DNA fragment will have a smaller overall bend, and the ER-DNA complex will migrate more rapidly through the gel. By monitoring the migration of the ER-DNA complexes, it is possible to determine the magnitude and direction of an ER-induced DNA bend.

32P-labeled DNA fragments containing an ERE and an intrinsic DNA bend were incubated with purified, baculovirus-expressed ERalpha or ERbeta and separated on a nondenaturing polyacrylamide gel. When the DNA fragment contained an ERE 32 bp upstream of the intrinsic DNA bend, the ERalpha -DNA complex migrated more rapidly (Fig. 3). This 32-bp spacing places the ERE and intrinsic DNA bend on the same side of the DNA helix. The rapid migration of the ERalpha -DNA complex indicates that the ERalpha -induced and intrinsic DNA bends must be out of phase. Since we know that the intrinsic DNA bend is oriented toward the minor groove of the DNA helix (55), the ERalpha -induced DNA bend must be directed toward the major groove of the DNA helix. Combined data from four independent experiments indicated that the ERalpha -directed DNA bend was 11.0 ± 1.6°. These findings are in good agreement with earlier work examining ERalpha -induced DNA bending (37). Surprisingly, when ERbeta was incubated with these same DNA fragments, none of the ERbeta -bound DNA fragments consistently migrated farther than the others in 10 independent experiments, demonstrating that ERbeta does not induce a directed bend in ERE-containing DNA fragments. Only ERalpha was capable of inducing a directed bend in these ERE-containing DNA fragments and that bend was directed toward the major groove of the DNA helix. Thus, our results with ERbeta are in stark contrast to our previous studies of 11 different wild type and mutant ERalpha proteins, each of which induced a DNA bend directed toward the major groove of the DNA helix (36, 37, 56).2


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 3.   ER-induced DNA bending. 32P-labeled DNA fragments containing 26, 28, 30, 32, 34, or 36 bp upstream of an intrinsic DNA bend were incubated with purified, baculovirus-expressed ERalpha or ERbeta and fractionated on a nondenaturing polyacrylamide gel. 32P- Labeled DNA bending standards were run on the same gel.

The DNA Binding Domain and Hinge Region of ERalpha , but Not ERbeta , Induce a Directed Bend in ERE-containing DNA Fragments-- We have previously demonstrated that wild type, truncated, and mutant ERalpha s induce a DNA bend toward the major groove of the DNA helix (36-38, 56) and were quite surprised that full-length ERbeta was incapable of inducing a directed DNA bend. To determine how this difference in ER-induced DNA bending might occur, we carried out phasing analysis with the region of the ER responsible for specific binding, the DBD. Because the DBD alone has a low affinity for the ERE (46, 57), the hinge region (domain D) was also included. The DBD and hinge region of ERalpha (CDalpha ) or ERbeta (CDbeta ) shown in Fig. 4 were expressed and purified. When the 32P-labeled DNA phasing probes were combined with purified CDalpha , the complex containing DNA fragments with 32 bp between the ERE and intrinsic DNA bend migrated the farthest (Fig. 5A). These findings demonstrate that CDalpha , like wild type, truncated, and mutant ERalpha s from our previous studies (36-38, 56), induced a bend directed toward the major groove of the DNA helix. Data from 11 independent experiments demonstrated that the magnitude of the CDalpha -directed DNA bend was 6.7 ± 0.6°. In contrast, the migration of the CDbeta -DNA complexes did not differ consistently, but followed the same pattern of migration as the free DNA indicating that CDbeta was incapable of inducing a directed DNA bend. These findings demonstrate that CDalpha could induce a bend toward the major groove of the DNA helix in ERE-containing DNA fragments, but CDbeta could not.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Schematic representation of full-length and truncated ER proteins. The domains (A-F) present in full-length ERalpha , ERbeta , CDalpha , CDbeta , CDalpha /beta , and CDbeta /alpha are schematically drawn. The locations of the N terminus, the DNA binding domain (DBD), the hinge region, and the ligand binding domain (LBD) are shown. Amino acid residues in ERalpha and ERbeta are numbered. The truncated hinge regions in CDalpha /beta and CDbeta /alpha define the boundaries of each C-terminal extension.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 5.   Determination of DBD-induced directed DNA bends. A, 32P-labeled ERE-containing DNA fragments were incubated with purified, bacterially expressed CDalpha or CDbeta and fractionated on a nondenaturing polyacrylamide gel. B, 32P-labeled ERE-containing DNA fragments were incubated with purified, bacterially expressed CDalpha /beta or CDbeta /alpha and fractionated on a nondenaturing polyacrylamide gel.

The amino acids that comprise the ERalpha and ERbeta DBDs are nearly identical. However, the hinge regions of these receptors vary significantly in amino acid sequence. Thus, we suspected that the hinge region of these two receptors might account for the difference in receptor-induced DNA bending we observed. Previous studies with the Type II and orphan nuclear receptors have defined a region C-terminal to the DBD, the CTE, which has been implicated in stabilizing the DBD-DNA interaction (58-60). This region has also been implicated in stabilizing ER-DNA binding (46, 57). To determine whether the CTE of ERalpha and ERbeta played a role in DNA bending, chimeric proteins were expressed, purified, and used in phasing analysis experiments (Fig. 4). These proteins contained the ERalpha DBD and the ERbeta CTE (CDalpha /beta ) or the ERbeta DBD and the ERalpha CTE (CDbeta /alpha ). When these proteins were combined with the 32P-labeled DNA fragments containing an ERE and an intrinsic DNA bend, the migration of complexes containing CDbeta /alpha chimera varied when the orientation of the CDbeta /alpha -induced and intrinsic DNA bends was altered. The complex containing 34 bp between the ERE and intrinsic DNA bend consistently migrated more rapidly than the other CDbeta /alpha -containing complexes (Fig. 5B). Assuming 10.5 nucleotides per DNA turn, CDbeta /alpha , like the full-length ERalpha and CDalpha , induced a DNA bend directed toward the major groove of the DNA helix. Using data from six independent experiments, we determined that the magnitude of the CDbeta /alpha -induced DNA bend was 5.6 ± 0.7°. In contrast, when CDalpha /beta was utilized, the migration of protein-bound phasing probes mimicked the migration of unbound probes indicating that CDalpha /beta was unable to alter DNA conformation. Thus, the ERalpha CTE plays an important role in directed DNA bending.

DNA Bending Influences ER-mediated Transactivation-- Our in vitro binding assays demonstrated that ERalpha , CDalpha , and CDbeta /alpha induced DNA bending directed toward the major groove of the DNA helix, but that ERbeta , CDbeta , and CDalpha /beta failed to induce a directed DNA bend. To determine whether receptor-induced DNA bending might play a role in E2-mediated transactivation, another set of transfection assays was carried out. Reporter plasmids that contained an ERE alone or in combination with an intrinsic DNA bend directed toward the minor groove of the DNA helix were tested for their abilities to enhance ER-mediated transcription activation. When the reporter plasmid contained a single ERE (Fig. 6, ATC1), ERalpha significantly increased CAT activity in the presence of E2. The magnitude of the increase was less than observed in Fig. 1, however, because the ATC1 reporter plasmid contained a less potent promoter than ERE TATA-CAT used in those experiments. When the reporter plasmid contained a promoter with the centers of the intrinsic and ERalpha -induced DNA bends on the same sides of the DNA helix so that the intrinsic and induced DNA bends were out of phase (ATC1-OP), the level of E2-induced CAT activity was similar to the level observed with ATC1. When the reporter plasmid contained a promoter with the centers of the intrinsic and ERalpha -induced DNA bends on opposite sides of the DNA helix so that the intrinsic and induced DNA bends were in phase (ATC1-IP), the level of E2-induced CAT activity was greater than the level observed with ATC1 or ATC1-OP. These data suggest that orienting an intrinsic DNA bend so that it complements an ERalpha -induced DNA bend enhances ERalpha -mediated transcription.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   Influence of an intrinsic DNA bend on ERalpha - and ERbeta -mediated transcription. Cells were transiently transfected with a human ERalpha or ERbeta expression vector, a reporter plasmid containing an ERE (ATC1) alone or in combination with an intrinsic DNA bend that is out of phase (ATC1-OP) or in phase (ATC1-IP) with the ERalpha -induced DNA bend, and a beta -galactosidase control vector and treated with ethanol vehicle (open bars) or 10 nM E2 (shaded bars). Data from three independent experiments were combined and are expressed as the mean ± S.E. Student's t tests were used to determine whether statistical differences between ethanol- and E2-treated groups existed. Asterisks (*) indicate significant differences in CAT activity in the ethanol- and E2-treated cells (p < 0.05).

When the ERbeta expression plasmid was utilized in transfection assays, no increase in CAT activity was observed with ATC1, again reflecting the decreased potency of the ATC1 promoter compared with the ERE TATA-CAT promoter (Fig. 1). When ATC1-OP was utilized, ERbeta was still transcriptionally inert. However, when ATC1-IP was utilized, ERbeta was capable of substantially increasing CAT activity in the presence of E2. These combined experiments are consistent with previous studies carried out with ERalpha in CHO cells (36) and highlight the importance of DNA bending and the orientation of that bend in E2-mediated transactivation.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have demonstrated that ERalpha and ERbeta have different abilities to activate transcription and alter DNA structure. Although both ERalpha and ERbeta can distort DNA structure, only ERalpha can induce a directed DNA bend. Taken together with earlier studies, we have now demonstrated that wild type ERalpha and 10 different ERalpha mutants induce directed DNA bending (36, 37, 56).2 These 11 ERalpha proteins all contained the CTE, and all induced a bend directed toward the major groove of the DNA helix. Even the smallest ERalpha construct utilized, which included the ERalpha DBD and hinge region (CDalpha ), was capable of inducing a bend directed toward the major groove of the DNA helix. However, when the ERalpha DBD was combined with the ERbeta CTE (CDalpha /beta ), the chimeric protein failed to bend ERE-containing DNA fragments. Neither full-length ERbeta nor the DBD and hinge region of ERbeta (CDbeta ) was capable of inducing a directed DNA bend. However, if the ERbeta DBD was combined with the ERalpha CTE (CDbeta /alpha ), this chimeric protein gained the ability to bend ERE-containing DNA fragments. Thus, replacing the ERbeta CTE with the ERalpha CTE resulted in a gain-of-function and replacing the ERalpha CTE with the ERbeta CTE resulted in a loss-of-function. Taken together, these combined experiments highlight the importance of the ERalpha CTE in receptor-induced DNA bending.

The amino acids that comprise the human ERalpha and ERbeta DBDs are 96% conserved and differ by only two amino acids (12, 61). However the CTE adjacent to the DBD varies substantially in amino acid sequence. Our experiments demonstrate that the ERalpha CTE plays a critical role in receptor-induced DNA bending. It is unclear at this point whether the entire ERalpha CTE or a specific domain within the ERalpha CTE is required for inducing these structural changes in ERE-containing DNA fragments. Interestingly, the type II thyroid hormone and retinoid X receptors and the orphan receptor RevErb contain ordered structures in the CTE that interact with the minor groove of the DNA helix and stabilize the protein-DNA interaction (58-60). Of particular interest is the Grip-box in the RevErb CTE, which forms direct contacts with bases in the minor groove. In contrast to these nuclear receptors, the ERalpha CTE is unstructured. However, it is possible that a region in the ERalpha CTE plays a similar role in stabilizing the receptor-DNA interaction and fostering structural changes in ERE-containing DNA fragments.

The ability of a protein to induce conformational changes in DNA structure is not limited to ERalpha and beta . A number of nuclear receptors induce DNA bending upon binding to their cognate response elements including the retinoid X receptor, thyroid hormone receptor, glucocorticoid, and progesterone receptors (62-66). Proteins involved in the formation of transcription complexes also induce DNA bending. Crystal structure analysis has revealed that T7 RNA polymerase induces a 63o bend (67). This polymerase-induced DNA bending has been implicated in lowering the DNA melting point to allow for separation of the DNA strands and initiation of transcription. Fos/Jun heterodimers and Jun/Jun homodimers induce bends oriented in opposite directions (54), which may influence their abilities to recruit and interact with different transcription factors. LEF1- and SRY-induced DNA bending appears to play a role in formation of higher order transcription complexes (68-70). The C-terminal zinc finger of the GATA-1 transcription factor induces a DNA bend that allows for homodimerization and stable DNA binding (71). Prokaryotic transcription factors, including the Borrelia burgdorferi Hbb protein, which is thought to be important in bacterial DNA replication (72), numerous cytosine-5 methyltransferases (73), and the E. coli catabolite activator protein CAP (74) cause conformational changes in their cognate DNA recognition sequences. Thus, the modification of DNA structure by proteins involved in DNA replication, modification, and transcription activation is widely used in both prokaryotic and eukaryotic systems.

Our laboratory and others have documented the enhanced ability of ERalpha to activate transcription of reporter plasmids in transient transfection experiments compared with ERbeta (11, 12, 20, 23, 43, 75). We have now demonstrated that full-length ERalpha , CDalpha , and a CDbeta /alpha chimera induce directed DNA bending but that full-length ERbeta , CDbeta , and a CDalpha /beta chimera cannot. The ability of an appropriately aligned DNA bend to enhance E2-mediated transcription provides evidence that changes in DNA structure can influence ERalpha -mediated transactivation. Furthermore, the fact that an appropriately positioned intrinsic DNA bend is able to help establish ERbeta -mediated estrogen responsiveness substantiates the role of DNA bending in ERbeta -mediated transactivation. It seems possible that the decreased ability of ERbeta to activate transcription may in part be due to its limited ability to induce changes in DNA flexibility and directed bending. ER-induced changes in DNA architecture could provide structural motifs required for recruitment of transcription factors or the scaffolding required for assembly of a basal transcription complex. Alternatively, DNA bending could help stabilize DNA loop formation and foster binding and interaction of multiple DNA-bound transcription factors. Our combined studies suggest that DNA bending influences the ability of ERalpha and ERbeta to activate transcription and that intrinsic and protein-induced changes in DNA structure could play an important role in regulating expression of estrogen-responsive genes in target cells.

    ACKNOWLEDGEMENTS

We thank James Kadonaga and Lee Kraus for viral stock used in producing ERalpha , Arthur Landy for DNA bending standards, Sietse Mosselman for the ERbeta expression vector, David Shapiro for the pET-21b(+):flag:hERalpha DBD expression plasmid, and Jennifer Wood and Lawrence Petz for providing valuable insight and advice.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant DK 53884 (to A. M. N.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by National Institutes of Health Cell and Molecular Biology Training Grant (T32 GM07283).

** To whom correspondence should be addressed: Dept. of Molecular and Integrative Physiology, Univ. of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 S. Goodwin Ave., Urbana, IL 61801. Tel.: 217-244-5679; Fax: 217-333-1133; E-mail: anardull@life.uiuc.edu.

Published, JBC Papers in Press, December 31, 2001, DOI 10.1074/jbc.M108491200

2 J. R. Schultz and A. M. Nardulli, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ER, estrogen receptor; ERE, estrogen response element; CHO, Chinese hamster ovary; CD, DNA binding and hinge domains; DBD, DNA binding domain; E2, 17beta -estradiol; CTE, C-terminal extension.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Korach, K. S. (1994) Science 266, 1524-1527[Abstract/Free Full Text]
2. Hess, R. A., Bunick, D., Lee, K.-H., Bahr, J., Taylor, J. A., Korach, K. S., and Lubahn, D. B. (1997) Nature 390, 509-512[CrossRef][Medline] [Order article via Infotrieve]
3. Subbiah, M. T. R. (1998) Proc. Soc. Exp. Biol. Med. 217, 23-29[CrossRef][Medline] [Order article via Infotrieve]
4. Mendelsohn, M. E., and Karas, R. H. (1994) Curr. Opin. Cardiol. 9, 619-626[Medline] [Order article via Infotrieve]
5. Toran-Allerand, C. D. (1996) J. Steroid Biochem. Mol. Biol. 56, 169-178[CrossRef][Medline] [Order article via Infotrieve]
6. Turner, R. T., Riggs, B. L., and Spelsberg, T. C. (1994) Endocr. Rev. 15, 275-300[Abstract/Free Full Text]
7. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J.-M., Jeltsch, J.-M., Staub, A., Jensen, E., Scrace, G., Waterfield, M., and Chambon, P. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7889-7893[Abstract/Free Full Text]
8. Krust, A., Green, S., Argos, P., Kumar, V., Walter, P., Bornert, J.-M., and Chambon, P. (1986) EMBO J. 5, 891-897[Medline] [Order article via Infotrieve]
9. White, R., Lees, J. A., Needham, M., Ham, J., and Parker, M. (1987) Mol. Endocrinol. 1, 735-744[Abstract/Free Full Text]
10. Maxwell, B. L., McDonnell, D. P., Conneely, O. M., Schulz, T. Z., Greene, G. L., and O'Malley, B. W. (1987) Mol. Endocrinol. 1, 25-35[Abstract/Free Full Text]
11. Kuiper, G. G. J. M., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.-A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5925-5930[Abstract/Free Full Text]
12. Mosselman, S., Polman, J., and Dijkema, R. (1996) FEBS Lett. 392, 49-53[CrossRef][Medline] [Order article via Infotrieve]
13. Tremblay, G. B., Tremblay, A., Copeland, N., Gilbert, D. J., Jenkins, N. A., Labrie, F., and Giguere, V. (1997) Mol. Endocrinol. 11, 353-365[Abstract/Free Full Text]
14. Ogawa, S., Inoue, S., Watanabe, T., Hiroi, H., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. (1998) Biochem. Biophys. Res. Commun. 243, 122-126[CrossRef][Medline] [Order article via Infotrieve]
15. Ogawa, Y., Aizawa, S., Shirakawa, H., and Yoshida, M. (1995) J. Biol. Chem. 270, 9272-9280[Abstract/Free Full Text]
16. Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J.-A. (1997) Endocrinology 138, 863-870[Abstract/Free Full Text]
17. Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J.-A., and Korach, K. S. (1997) Endocrinology 138, 4613-4621[Abstract/Free Full Text]
18. Onoe, Y., Miyaura, C., Ohta, H., Nozawa, S., and Suda, T. (1997) Endocrinology 138, 4509-4512[Abstract/Free Full Text]
19. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. (1996) J. Clin. Endocrinol. Metab. 82, 2371-2374[Abstract/Free Full Text]
20. Cowley, S. M., Hoare, S., Mosselman, S., and Parker, M. G. (1997) J. Biol. Chem. 272, 19858-19862[Abstract/Free Full Text]
21. Tremblay, G. B., Tremblay, A., Labrie, F., and Giguere, V. (1998) Cancer Res. 58, 877-881[Abstract/Free Full Text]
22. Wood, J. R., Greene, G. L., and Nardulli, A. M. (1998) Mol. Cell. Biol. 18, 1927-1934[Abstract/Free Full Text]
23. Loven, M. A., Wood, J. A., and Nardulli, A. M. (2001) Mol. Cell. Endocrinol. 181, 151-163[CrossRef][Medline] [Order article via Infotrieve]
24. Wood, J. R., Likhite, V. S., Loven, M. A., and Nardulli, A. M. (2001) Mol. Endocrinol. 15, 1114-1126[Abstract/Free Full Text]
25. Loven, M. A., Likhite, V. S., Choi, I., and Nardulli, A. M. (2001) J. Biol. Chem. 276, 45282-45288[Abstract/Free Full Text]
26. Steitz, T. A. (1990) Q. Rev. Biophys. 23, 205-280[Medline] [Order article via Infotrieve]
27. Frankel, A. D., and Kim, P. S. (1991) Cell 65, 717-719[CrossRef][Medline] [Order article via Infotrieve]
28. Pabo, C. O., and Sauer, R. T. (1992) Annu. Rev. Biochem. 61, 1053-1095[CrossRef][Medline] [Order article via Infotrieve]
29. Alber, T. (1993) Curr. Biol. 3, 182-184
30. von Hippel, P. H. (1994) Science 263, 769-770[Free Full Text]
31. Spolar, R. S., and Record, M. T. (1994) Science 263, 777-784[Abstract/Free Full Text]
32. Nardulli, A. M., and Shapiro, D. J. (1992) Mol. Cell. Biol. 12, 2037-2042[Abstract/Free Full Text]
33. Nardulli, A. M., and Shapiro, D. J. (1993) Receptor 3, 247-255[Medline] [Order article via Infotrieve]
34. Nardulli, A. M., Greene, G. L., and Shapiro, D. J. (1993) Mol. Endocrinol. 7, 331-340[Abstract/Free Full Text]
35. Shapiro, D. J., Greene, G. L., and Nardulli, A. M. (1993) in Steroid Hormone Receptors: Basic and Clinical Aspects (Moudgil, V. K., ed) , pp. 75-105, Birkhauser, Boston, MA
36. Nardulli, A. M., Grobner, C., and Cotter, D. (1995) Mol. Endocrinol. 9, 1064-1076[Abstract/Free Full Text]
37. Potthoff, S. J., Romine, L. E., and Nardulli, A. M. (1996) Mol. Endocrinol. 10, 1095-1106[Abstract/Free Full Text]
38. Landel, C. C., Potthoff, S. J., Nardulli, A. M., Kushner, P. J., and Greene, G. L. (1997) J. Steroid Biochem. Mol. Biol. 63, 59-73[CrossRef][Medline] [Order article via Infotrieve]
39. Kim, J., de Haan, G., Nardulli, A. M., and Shapiro, D. J. (1997) Mol. Cell. Biol. 17, 3173-3180[Abstract]
40. Sabbah, M., Le, Ricousse, S., Redeuilh, G., and Baulieu, E.-E. (1992) Biochem. Biophys. Res. Commun. 185, 944-952[CrossRef][Medline] [Order article via Infotrieve]
41. Nardulli, A. M., Romine, L. E., Carpo, C., Greene, G. L., and Rainish, B. (1996) Mol. Endocrinol. 10, 694-704[Abstract/Free Full Text]
42. Reese, J. C., and Katzenellenbogen, B. S. (1991) Nucleic Acids Res. 19, 6595-6602[Abstract/Free Full Text]
43. McInerney, E. M., Weis, K. E., Sun, J., Mosselman, S., and Katzenellenbogen, B. S. (1998) Endocrinology 139, 4513-4522[Abstract/Free Full Text]
44. Chang, T.-C., Nardulli, A. M., Lew, D., and Shapiro, D. J. (1992) Mol. Endocrinol. 6, 346-354[Abstract/Free Full Text]
45. Herbomel, P., Bourachot, B., and Yaniv, M. (1984) Cell 39, 653-662[CrossRef][Medline] [Order article via Infotrieve]
46. Melvin, V. M. S., and Edwards, D. P. (2001) Proceedings, 83rd Annual Endocrine Society Meeting, June 20-23, Denver, CO, June, The Endocrine Society, p. 100
47. Thompson, J. F., and Landy, A. (1988) Nucleic Acids Res. 16, 9687-9705[Abstract/Free Full Text]
48. Chodosh, L. A., and Buratowski, S. (1989) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 2 , pp. 12.2.1-12.2.10, Greene Publishing Associates and Wiley Interscience, New York
49. Kerppola, T. K., and Curran, T. (1991) Science 254, 1210-1214[Abstract/Free Full Text]
50. Wolffe, A. P. (1994) Science 264, 1100-1101[Free Full Text]
51. van der Vliet, P. C., and Verrijzer, C. P. (1993) Bioessays 15, 25-32[CrossRef][Medline] [Order article via Infotrieve]
52. Werner, M. H., Gronenborn, A. M., and Clore, G. M. (1996) Science 271, 778-784[Abstract]
53. Crothers, D. M., Haran, T. E., and Nadeau, J. G. (1990) J. Biol. Chem. 265, 7093-7096[Free Full Text]
54. Kerppola, T. K., and Curran, T. (1994) in Nucleic Acids and Molecular Biology (Eckstein, F. , and Lilley, D., eds), Vol. 7 , pp. 70-105, Springer, New York
55. Zinkel, S. S., and Crothers, D. M. (1987) Nature 328, 178-181[CrossRef][Medline] [Order article via Infotrieve]
56. Lazennec, G., Ediger, T., Petz, L., Nardulli, A., and Katzenellenbogen, B. (1997) Mol. Endocrinol. 11, 1375-1386[Abstract/Free Full Text]
57. Mader, S., Chambon, P., and White, J. H. (1993) Nucleic Acids Res. 21, 1125-1132[Abstract/Free Full Text]
58. Lee, M. S., Kliewer, S. A., Provencal, J., Wright, P. E., and Evans, R. M. (1993) Science 260, 1117-1121[Abstract/Free Full Text]
59. Rastinejad, F., Perlmann, T., Evans, R. M., and Sigler, P. B. (1995) Nature 375, 203-211[CrossRef][Medline] [Order article via Infotrieve]
60. Zhao, Q., Khorasanizadeh, S., Miyoshi, Y., Lazar, M. A., and Rastinejad, F. (1998) Mol. Cell 1, 849-861[CrossRef][Medline] [Order article via Infotrieve]
61. Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. (1986) Science 231, 1150-1154[Abstract/Free Full Text]
62. Lu, X. P., Eberhardt, N. L., and Pfahl, M. (1993) Mol. Cell. Biol. 13, 6509-6519[Abstract/Free Full Text]
63. Shulemovich, K., Dimaculangan, D. D., Katz, D., and Lazar, M. A. (1995) Nucleic Acids Res. 23, 811-818[Abstract/Free Full Text]
64. Leidig, F., Shepard, A. R., Zhang, W., Stelter, A., Cattini, P. A., Baxter, J. D., and Eberhardt, N. L. (1992) J. Biol. Chem. 267, 913-921[Abstract/Free Full Text]
65. Prendergast, P., Pan, Z., and Edwards, D. P. (1996) Mol. Endocrinol. 10, 393-407[Abstract/Free Full Text]
66. Petz, L., Nardulli, A., Kim, J., Horwitz, K., Freedman, L., and Shapiro, D. (1997) J. Steroid Biochem. Mol. Biol. 60, 31-41[CrossRef][Medline] [Order article via Infotrieve]
67. Ujvari, A., and Martin, C. T. (2000) J. Mol. Biol. 295, 1173-1184[CrossRef][Medline] [Order article via Infotrieve]
68. Giese, K., Amsterdam, A., and Grosschedl, R. (1991) Genes Dev. 5, 2567-2578[Abstract/Free Full Text]
69. Giese, K., Cox, J., and Grosschedl, R. (1992) Cell 69, 185-195[CrossRef][Medline] [Order article via Infotrieve]
70. Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R., and Wright, P. E. (1995) Nature 376, 791-795[CrossRef][Medline] [Order article via Infotrieve]
71. Ghirlando, R., and Trainor, C. D. (2000) J. Biol. Chem. 275, 28152-28156[Abstract/Free Full Text]
72. Kobryn, K., Naigamwalla, D. Z., and Chaconas, G. (2000) Mol. Microbiol. 37, 145-155[CrossRef][Medline] [Order article via Infotrieve]
73. Rasko, T., Finta, C., and Kiss, A. (2000) Nucleic Acids Res. 28, 3083-3091[Abstract/Free Full Text]
74. Schultz, S. C., Shields, G. C., and Steitz, T. A. (1991) Science 253, 1001-1007[Abstract/Free Full Text]
75. Jones, P. S., Parrott, E., and White, I. N. H. (1999) J. Biol. Chem. 274, 32008-32014[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
J. R. Schultz-Norton, V. A. Gabisi, Y. S. Ziegler, I. X. McLeod, J. R. Yates, and A. M. Nardulli
Interaction of estrogen receptor {alpha} with proliferating cell nuclear antigen
Nucleic Acids Res., August 1, 2007; 35(15): 5028 - 5038.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. R. Schultz-Norton, K. A. Walt, Y. S. Ziegler, I. X. McLeod, J. R. Yates, L. T. Raetzman, and A. M. Nardulli
The Deoxyribonucleic Acid Repair Protein Flap Endonuclease-1 Modulates Estrogen-Responsive Gene Expression
Mol. Endocrinol., July 1, 2007; 21(7): 1569 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Kawai, A. Ishii, K. Washiya, T. Konno, H. Kon, C. Yamaya, I. Ono, Y. Minamiya, and J. Ogawa
Estrogen Receptor {alpha} and {beta} are Prognostic Factors in Non-Small Cell Lung Cancer
Clin. Cancer Res., July 15, 2005; 11(14): 5084 - 5089.
[Abstract] [Full Text] [PDF]


Home page
Proc R Soc BHome page
M.B Hawkins, J Godwin, D Crews, and P Thomas
The distributions of the duplicate oestrogen receptors ER-{beta}a and ER-{beta}b in the forebrain of the Atlantic croaker (Micropogonias undulatus): evidence for subfunctionalization after gene duplication
Proc R Soc B, March 22, 2005; 272(1563): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. X. Jin, Y.-W. Leu, S. Liyanarachchi, H. Sun, M. Fan, K. P. Nephew, T. H.-M. Huang, and R. V. Davuluri
Identifying estrogen receptor {alpha} target genes using integrated computational genomics and chromatin immunoprecipitation microarray
Nucleic Acids Res., December 17, 2004; 32(22): 6627 - 6635.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. E. Mysiak, C. Wyman, P. E. Holthuizen, and P. C. van der Vliet
NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication
Nucleic Acids Res., December 1, 2004; 32(21): 6218 - 6225.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A.G.B. Hurst, D.W. Goad, M. Mohan, and J.R. Malayer
Independent Downstream Gene Expression Profiles in the Presence of Estrogen Receptor {alpha} or {beta}
Biol Reprod, October 1, 2004; 71(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. A. Carr, J. Mead, and A. K. Vershon
{alpha}1-induced DNA bending is required for transcriptional activation by the Mcm1-{alpha}1 complex
Nucleic Acids Res., April 26, 2004; 32(8): 2298 - 2305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Melvin, C. Harrell, J. S. Adelman, W. L. Kraus, M. Churchill, and D. P. Edwards
The Role of the C-terminal Extension (CTE) of the Estrogen Receptor {alpha} and {beta} DNA Binding Domain in DNA Binding and Interaction with HMGB
J. Biol. Chem., April 9, 2004; 279(15): 14763 - 14771.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8702    most recent
M108491200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, J. R.
Right arrow Articles by Nardulli, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J. R.
Right arrow Articles by Nardulli, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement